Effect of Neutrophil-to-Lymphocyte Ratio on Post-TAVR Mortality and Periprocedural Pulmonary Hypertension

Table 4

3-month all-cause mortality of different PH groups.

	Pre-TAVR PH groups			Post-TAVR PH groups			Peri-TAVR PH variation groups
	No PH (n = 70)	PH (n = 56)		No PH Z(n = 90)	PH (n = 34)		No PH (n = 61)	Improved PH (n = 35)	Persistent PH (n = 28)
3-month all-cause mortality	4 (5.7%)	8 (14.3%)	0.131	6 (6.7%)	4 (11.8%)	0.460	2 (3.3%)	4 (11.4%)	4 (14.3%)	0.057

TAVR, transcatheter aortic valve replacement; PH, pulmonary hypertension.